The Compliance to Good Clinical Practice, Good Laboratory Practice, and Quality Assurance Track will feature best practices in quality systems, quality plans, quality metrics and CAPA’s and will provide an opportunity to learn about current regulatory authority activities related to GCPs.

At the conclusion of this meeting, participants should be able to:
• Describe how to avoid GCP/GLP noncompliance through innovation and collaboration in a period of increasing complexity and globalization in clinical trials

**Please note workshops that were made available during the Annual Meeting included attendee interactivity. Due to such format, audio recordings may not be available.